Codi QR

Sputnik V update: safety and neutralizing antibodies in healthy adults and adolescents

BackgroundDuring the COVID-19 pandemic, adenoviral vector-based Sputnik V vaccine was used to vaccinate the civilian population of 74 countries worldwide. As part of laboratory monitoring of the effectiveness of the Sputnik V vaccine, a decrease in effectiveness was detected against Omicron BA.5 and...

Descripció completa

Guardat en:
Autors principals: Inna V. Shuliakova, Daria M. Grousova, Anna A. Iliukhina, Alina S. Dzharullaeva, Nadezhda L. Lubenets, Maria K. Ordzhonikidze, Fatima M. Izhaeva, Alina S. Erokhova, Ilya D. Zorkov, Valentin V. Azizyan, Zoya D. Boeva, Dmitrii A. Reshetnikov, Irina A. Ermolova, Vladislav A. Lega, Anna V. Kovyrshina, Kirill M. Bukhtin, Lyubov P. Romanova, Ekaterina I. Alekseeva, Svetlana N. Borzakova, Svetlana A. Rachina, Marina G. Rusanova, Tatiana A. Ozharovskaia, Olga Popova, Denis I. Zrelkin, Olga V. Zubkova, Amir I. Tukhvatulin, Natalia M. Tukhvatulina, Dmitrii V. Shcheblyakov, Irina A. Favorskaya, Ilias B. Esmagambetov, Andrey P. Karpov, Aleksandr S. Semikhin, Andrey A. Pochtovyi, Boris S. Naroditskiy, Vladimir A. Gushchin, Aleksandr L. Gintsburg, Denis Y. Logunov
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2026-03-01
Col·lecció:Frontiers in Immunology
Matèries:
NtAb
SARS-CoV-2
Sputnik V
vaccine
XBB
Accés en línia:https://www.frontiersin.org/articles/10.3389/fimmu.2026.1736771/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars